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ABSTRACT 
 
The amounts of substances together with nutritional and medicinal properties of fruits from Berberidaceae family 
vary between the plant species. Aluminum chloride colorimetric assay was used for flavonoids determination in 250 
g of dried fruit. The Folin-Ciocalteau method was used to determine the total phenolic compound contents. The free 
radical-scavenging activity was examined by stable 1,1-diphenyl-2-picryl-hydrazyl radical (DPPH) assay. The level 
of total phenol in different Berberis Ecotypes was 241.5 mg/g for Black berberis khorasanica, 296.8 mg/g for Black 
berberis bakhtiarica and 157.5 mg/g for Red berberis khorasanica. Furthermore, anti-radical activities (IC50) of 
these three Iranian Berberis species were 221.1, 58.38 and 123.2 µg/mL respectively.  The level of flavonol in Black 
berberis khorasanica was approximately 2.42-fold higher than Black berberis bakhtiarica and 5.49-fold higher than 
Red berberis khorasanica. The content of flavonoids in Black berberis bakhtiarica was aproximately 2 times more 
than its level in Black berberis khorasanica and 3.55 times more than its level in Red berberis khorasanica. The 
highest amount of phenol and total phenols were observed in Black berberis bakhtiarica as its anti-radical activity 
was approximately 3.8 times more than Black berberis khorasanica and 2.1 times more than Red Berberis 
khorasanica. We showed high level of antioxidant compounds in Black berberis bakhtiarica. Considering the rate of 
elements and compounds in three Iranian Berberis ecotypes and based on their antioxidant and anti-radical effects, 
the berberis can be of benefit to oppose free radicals in the body. 
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INTRODUCTION 
 
Nowadays, due to the potential adverse effects of synthetic drugs and increasing contraindications to their usage, an 
increasing interest can be seen in the use of medicinal plants [1]. Plants with antioxidant activity have been used to 
treat various diseases. Recent researches have also shown promising results from these plants in the treatment or 
prevention of hard curable conditions such as diabetes[2, 3], atherosclerosis[4, 5], hypertension[5-7], and cancer[8, 
9]. These herbal medicines have also the capacities to diminish drug induced adverse effects[10, 11] and even heavy 
metal toxicities[7, 12]. The antioxidant activities of these plants have been attributed to their flavonoids and 
phenolic components[13, 14]. 
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Berberidaceae family is one of these plants, which are found worldwide, and its family has about 650 species. 
Berberis is native plant of temperate and subtropical regions of Europe, Asia, Africa, North and South America. 
Various ecotypes of Berberis grow well throughout different parts of Iran. Several parts of plant including roots, 
shoot, leaf and fruit can be used as medicine or food stuff [15-17]. In Iran, Berberis seems to have 5 woody species 
i. e., shrubs and bushes. Two ecotypes of Berberis including Berberis bakhtiarica and Berberis khorasanica are 
explosively belonged to Iran and Berberis integerrima and Berberis crataegina are found in Iran as well as other 
regions including East Anatolia, East Iraq, Afghanistan, Transcaucasia, Turkmenistan, West Pakistan, Kashmir and 
Central Asia. Several species of this family were recently imported to Iran to use in different, areas as ornamental 
[18, 19].  
 
Medicinal herbs and their derivatives have long been used as potential remedies for a wide range of illnesses, 
however, valid researches have not yet fully proved their definite effects[20]. 
 
There is a considerable interest for Nutraceuticals and functional foods have as potential alternative therapies in 
order to for treat various insulin resistance and cardiovascular disorders.  
 
Previous studies on glucose and lipid profile demonstrated the safety and effectiveness of a combination of Barberry 
extract in patients samples [21, 22] and it has been approved by FDA[23]. This fruit is used as a condiment and 
flavoring supplrmernt in Iran and parts of Asia. Berberis fruit has a variety of nutritional constituents such as 
dextrose, fructose, malic acid, tartaric acid, citric acid, pectin, resin and also is rich in vitamin C, vitamin A, 
calcium, iron and potassium[24, 25]. The medicinal properties of this plant is attributed to Berberine. Berbamine 
alkaloids, Oxyaconthine, bervulcine, columbamine and ascorbic acid are found in the chemical composition of 
different parts of the plant. Berberis is used in the treatment of various diseases such as scurvy, hypertension, 
Alzheimer, depression, diarrhea, diabetes, jaundice, kidney stones, gout, rheumatism and skin diseases[26, 27]. 
 
Berberis fruit, as industrial application, is also used as the natural colors in the food industry to its anthocyanin [28]. 
In Iran, different organs of the plant especially its fruit, has been used in the treatment of diabetes, fatty liver, 
hypertension, anemia, cardiovascular system, gastrointestinal, genitourinary and breathing complications [29]. 
According to the geographical conditions, weather, and its different traditionally reported medicinal effects, it 
sounds to be one of the most important crops in both agricultural and pasture sectors [30, 31]. In the other hand, 
Iranian local therapists (herbalists) prescribe and recommend it for the treatment of various diseases. Therefore, this 
study aimed to determine the amount of minerals, antioxidants and anti-radical activity of three Iranian Berberis 
ecotypes including Black berberis bakhtiarica, Black berberis khorasanica and Red berberis integerrima from 
which the latest is not stone fruits. 
 
MATERIALS AND METHODS 
 
1. Plant material 
A total amount of 250 g of dried fruit from each ecotype were acquired from the medicinal herbs stores in Lordegan 
and Mashhad cities, Iran. The Dried fruit were cleaned from impurities and prepared for laboratory studies. 
 
2. Chemicals  
Aluminum chloride, methanol, potassium acetate, sodium acetate, Folin-Ciocalteu reagent, Gallic acid, Na2CO3, 
DPPH and BHA were purchased from Merck, USA. The highest purity available commercially of all other 
chemicals and reagents were used to ensure the best results.  
 
3. Total flavonoids determination 
Aluminum chloride colorimetric assay was used for flavonoids determination as described previously [32]. Each 
plant extracts (0.5 ml of 1:10 g ml-1) in methanol were separately mixed with 1.5 ml of methanol, 0.1 ml of 10% 
aluminum chloride, 0.1 ml of 1 M potassium acetate and 2.8 ml of distilled water. The solution was incubated at 
room temperature for 30 min then the absorbance of the reaction mixture was measured at 415 nm with a double 
beam Perkin Elmer UV/Visible spectrophotometer (USA).  
4. Total phenols determination 
The Folin-Ciocalteau method was used to determine the total phenolic compound contents [33, 34]. A diluted 
sample of each plant extract (0.5ml of 1:10 g ml-1) or gallic acid (standard phenolic compound) was mixed with 
Folin-Ciocalteu reagent (5 ml, 1:10 diluted with distilled water) and aqueous Na2CO3 (4 ml, 1 M). The mixtures 
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were left at room temperature for 15 min and the total phenols were determined by colorimetry at 765 nm. The 
standard curve was prepared using 0, 50, 100, 150, 200, 250 mg L-1 solutions of gallic acid in methanol: water 
(50:50, v/v). Total phenol values are expressed in terms of gallic acid equivalent (mg g –1 of dry mass), which is a 
common reference compound [35]. 
 
5. DPPH radical-scavenging activity  
Determination of free radical-scavenging activity of the extracts was perform using the stable 1,1-diphenyl-2-picryl 
hydrazyl radical (DPPH) assay[33]. Different concentrations of each extracts were added, at an equal volume, to 
methanolic solution of DPPH (100 µM). After incubation for 15 min at room temperature, the absorbance was 
recorded at 517 nm. The IC50 values denote the concentration of sample, which is required to scavenge 50% of 
DPPH free radicals[35]. 
 
6.  Digestion procedures  
In order to compare the minerals and elements in dried fruit samples three sample digestion procedures were tested 
to prepare dry and wet digestion samples. While the dry digestion was mainly used to measure the amount of Fe, Zn, 
Cu, Mg and Cd, the wet digestion procedure was chosen for measuring  N, P, Ca , Mn and K [36]. 
 
6.1. Dry digestion 
A total of 1.0 g of dried fruit samples were placed into a high-form porcelain crucible. The furnace temperature was 
slowly increased to 450 °C. The samples were ashed for about 16 h until a white ash residue was obtained. The ash 
samples were treated with 5 ml HNO3 (25% v/v) and the mixtures were heated slowly to dissolve the residue if 
needed. The resulting solutions were filtered through whatman filter papers and then transferred to a 10 ml 
volumetric flask and the volume was adjusted for each sample. Blanks were prepared in the same way but omitting 
the sample. The determination of metal contents in this clear solution was carried out by ICP-OES. Three replicates 
(acid digests) were performed for each sample [36]. 
 
6.2. Wet digestion 
For the digestion of samples, the temperature was maintained at 130 °C for 4 h during digestion of 1.0 g of sample 
with 6 ml HNO3 (65%) and 2 ml H2O2 (30%) mixtures on the hot plate until complete solubilization of samples, 
then diluted to 10 ml with distilled water. The residue was filtered through whatman filter paper and then the 
samples were diluted to 10 mL with distilled water. Element contents of final solution were determined by ICP-
OES. Blanks were prepared in the same way omitting the sample. Three replicates (acid digests) were performed for 
each sample [36]. 
 
7. Statistical tests 
All the experiments were performed in three biological replicated. The average and standard deviations were 
calculated using SPSS software version 22. 
 
RESULTS AND DISCUSSION 
 
The obtained results about flavonol, flavonoids and total phenolic contents in the fruit of three Iranian Berberis are 
exhibited in Table 1. As shown, flavonol content of Black berberis khorasanica was 2 times more than Black 
berberis bakhtiarica  and 5 times higher than  Red berberis khorasanica. Flavonoids content in Black berberis 
bakhtiarica was over 2-fold higher than Black berberis khorasanica and over 3-fold higher than Red berberis 
khorasanica. The highest amount of phenolic content was related to Black berberis bakhtiarica. 
 
Table 1. Amounts of flavonols, flavonoids and phenolic compounds found in the fruits of three Iranian Berberis species 
 
Berberis  species Flavonol Mg/g 
Flavonoid 
Mg/g 
Phenol 
Mg/g 
Total phenol 
Mg/g 
Black berberis khorasanica 138.9 ± 2.8 21.73 ± 1.2 0.76 ± 0.021 241.23 ± 4.29 
Black berberis bakhtiarica 57.43± 1.85 43.36 ± 1.55 0.89 ± 0.025 296.43 ± 7.46 
Red berberis khorasanica 25.26± 1.65 12.23 ± 0.95 0.53 ± 0.02 157.3 ± 8.15 
 
The anti-radical activities of three Iranian Berberis species are listed in Table 2. As seen, the anti-radical activity of 
Black berberis bakhtiarica is around 4 times higher than Black berberis khorasanica and 2 times higher than Red 
berberis khorasanica . 
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Table 2. Anti-radical activities (DPPH) of three Iranian Berberis species 
 
Berberis species IC50 µg/mL 
Black berberis khorasanica  221.10  ± 5.60 
Black berberis bakhtiarica 58.38  ± 7.53 
Red berberis khorasanica  123.20  ± 6.48 
 
The amounts of minerals and constituents in three Iranian Berberis species are presented in Table 3. In two species 
of Black berberis bakhtiarica and Black berberis khorasanica, the concentration of magnesium in Black berberis 
bakhtiarica was 2 fold higher than Black berberis khorasanica and Zn concentration in Black berberis khorasanica 
was 1.5 times more than Black berberis bakhtiarica while in other cases both of them were similar. Moreover, iron 
concentration in  Red berberis khorasanica was about 5 times greater than Blak berberis. Also, Zn content in Black 
berberis was lower than half in Red berbery. Nitrogen and Cu concentration in both Black berberis was lower than 
threshold. 
 
Table 3. The concentration of elements in fruits of three Iranian Berberis species 
 
Specimen N % 
P 
% 
K 
% 
Ca 
% 
Mg 
% 
Cd 
mg.kg - 1 
Fe 
mg.kg – 1 
Zn 
mg.kg - 1 
Cu 
mg.kg – 1 
Mn 
mg.kg - 1 
Black berberis khorasanica 2.06 
± 0.18 
0.24 
±0.01 
1.53 
±0.28 
0.073 
±0.015 
0.197 
±0.016 
1.51 
±0.22 
468.83 
±42.52 
78.43 
±9.87 
47.37 
±3.46 
48.82 
±1.92 
Black berberis bakhtiarica 2.46 
± 0.14 
0.26 
±0.04 
1.08 
±0.08 
0.173 
±0.016 
0.479 
±0.023 
1.18 
±0.12 
415.53 
±26.82 
55.37 
±5.27 
49.84 
±3.03 
46.37 
±1.71 
Red berberis khorasanica 1.28 
± 0.16 
0.28 
±0.04 
1.06 
±0.06 
0.157 
±0.021 
0.541 
±0.034 
1.63 
±0.28 
2650.34 
±290.57 
27.53 
±3.52 
33.67 
±2.69 
58.61 
±5.81 
 
This study aimed to determine the amounts of minerals, antioxidants and anti-radical activity involved in the fruits 
of three Iranian Berberis species. Free radicals play an important and deteriorative effect in human health. Based on 
the results of present study Berberis fruit with marked antioxidants and anti-radical compounds can lead to prevent 
different diseases in human beings. The role of copper and zinc elements particularly in Cu/Zn-superoxide 
dismutase activity is very important[37]. and three Berberis fruits showed significant amount of both elements. Also 
in accordance with the work of Rezatalab who concluded that anti-oxidant properties of seed oil of Berberis 
integerrima was at high level [38]. The results of present study indicated that the amount of phosphorous, copper, 
zinc, iron, sodium and potassium were different among the fruits of studied Berberis species. This outcome is not in 
line with the published results of Berenji work concerning the concentration level of some elements which sounds to 
be justifiable with regard to measurement method, and different in crop harvesting [17]. Berberis has been 
recommended in various Iranian dishes. Traditional physicians also use it in order to treat many diseases. It seems 
that patients with more iron accumulation in their body, including thalassemia and patients treated with blood 
products should be cautious about using Red berberis khorasanica because of high iron level. Otherwise, this 
maintenance treatment approach will lead to iron accumulation in different tissues, damaging them. However, the 
antioxidant effect of this fruit might be useful in liver damage resulted from iron accumulation in liver tissue in 
thalassemic patients due to a crucial role in reduction of fat-soluble antioxidants[39]. So, to come up with this 
problem use of Black berberis should to be useful for the reason of higher amount of anti-oxidant and anti-radical 
activity in one hand and lower iron contents in the other hands. Furthermore, Black berberis khorasanica compared 
with other Berberis species like Red Berberis and some anthocyanin-rich fruits such as berries, blackberries, 
raspberries, and cranberries contain high level of anthocyanin. The results demonstrated that Berberis as Iranian 
native and wild fruit is rich in antioxidant compositions which could improve public health level [40,41]. According 
to the prevalence of iron deficiency anemia throughout the world especially in Iran, the prevalence of this illness in 
developing countries (estimated to be 28.5%, in southern Iran and 5-8% in industrialized countries), the prevalence 
of these diseases can be prevented in the community through incorporating more Red berberis khorasanica in their 
diets[42].  
 
CONCLUSION 
 
This study shows that the amount of antioxidant compounds in Black berberis of Chaharmahal Va Bakhtiari 
province was high. With regard to the role of zinc in physiological actions, both Black berberis of Khorasan and 
Chaharmahal Va Bakhtiari provinces contain significant amounts of these two elements. Red berberis khorasanica, 
used mostly in Iranian foods, had significant amounts of iron and seems to be beneficial for iron deficient patients; 
however, in patients with high iron storage it should be used with caution. Many medicinal plants native to Iran 
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contain pharmaceutical active ingredients and flavonoid antioxidants and flavonoids, and many medicinal and 
therapeutic effects due to the presence of these materials [42-74]. These plants may have the same effects and worth 
examining. 
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